Detection of Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Detection of Antimicrobial Resistance. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Detection of Antimicrobial Resistance Indian Medical PG Question 1: All are true about ESBL except -
- A. Resistant to carbapenems (Correct Answer)
- B. Classification is based on 3rd generation cephalosporin sensitivity
- C. Cephalosporin sensitivity testing is required to confirm ESBL
- D. Ambler classification is based on molecular structure
Detection of Antimicrobial Resistance Explanation: ***Resistant to carbapenems***
- **ESBL (Extended-Spectrum Beta-Lactamase)**-producing bacteria are typically **susceptible to carbapenems**. Carbapenems are a primary treatment option for serious ESBL infections.
- Resistance to carbapenems suggests the presence of other resistance mechanisms, such as **carbapenemases**, not ESBLs.
*Classification is based on 3rd generation cephalosporin sensitivity*
- ESBLs are specifically defined by their ability to hydrolyze and confer resistance to **extended-spectrum cephalosporins** (e.g., ceftriaxone, ceftazidime) and aztreonam.
- This characteristic resistance to third-generation cephalosporins is key to their definition and clinical identification.
*Cephalosporin sensitivity testing is required to confirm ESBL*
- **Phenotypic confirmatory tests** for ESBLs involve demonstrating increased resistance to an extended-spectrum cephalosporin alone compared to the same cephalosporin combined with a **beta-lactamase inhibitor** like clavulanic acid.
- This testing is crucial for accurate detection and guiding appropriate antibiotic therapy.
*Ambler classification is based on molecular structure*
- The **Ambler classification system** categorizes beta-lactamases into classes A, B, C, and D based on their **amino acid sequence homology** and their active site mechanisms.
- This classification helps in understanding the biochemical properties and substrate profiles of different beta-lactamases, including ESBLs.
Detection of Antimicrobial Resistance Indian Medical PG Question 2: The disc diffusion method is also known as?
- A. Kirby-Bauer (Correct Answer)
- B. VDRL
- C. Dark field microscopy
- D. None of the options
Detection of Antimicrobial Resistance Explanation: ***Kirby-Bauer***
- The **Kirby-Bauer disc diffusion method** is a widely used and standardized technique for determining the **antimicrobial susceptibility** of bacteria.
- This method involves placing antibiotic-impregnated discs on an agar plate inoculated with bacteria, and the resulting **zones of inhibition** are measured.
*VDRL*
- **VDRL (Venereal Disease Research Laboratory)** is a non-treponemal serologic test used for screening and diagnosing **syphilis**, detecting antibodies to cardiolipin.
- It is a **flocculation test** that detects reagin antibodies and is not related to antimicrobial susceptibility testing.
*Dark field microscopy*
- **Dark field microscopy** is a type of light microscopy that illuminates the specimen from the sides, making it appear bright against a dark background.
- It is primarily used for visualizing **unstained, live microorganisms**, especially spirochetes like *Treponema pallidum*, and does not involve disc diffusion.
*None of the options*
- This option is incorrect because the disc diffusion method has a widely recognized alternative name, **Kirby-Bauer**.
Detection of Antimicrobial Resistance Indian Medical PG Question 3: A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?
- A. Vancomycin
- B. Teicoplanin
- C. Linezolid
- D. Imipenem (Correct Answer)
Detection of Antimicrobial Resistance Explanation: ***Imipenem***
- **Imipenem** is a carbapenem antibiotic that is effective against many Gram-positive and Gram-negative bacteria, but it is **not active against MRSA (methicillin-resistant *Staphylococcus aureus*)**.
- MRSA strains are resistant to all beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems like imipenem, due to the presence of the **mecA gene** which encodes for an altered penicillin-binding protein (PBP2a).
*Vancomycin*
- **Vancomycin** is a glycopeptide antibiotic that is a primary choice for treating **MRSA infections**, including cellulitis.
- It inhibits cell wall synthesis by binding to the D-Ala-D-Ala precursor, preventing cross-linking, and is specifically active against **Gram-positive bacteria**.
*Teicoplanin*
- **Teicoplanin** is another glycopeptide antibiotic, similar to vancomycin, and is also considered a suitable agent for treating **MRSA infections**.
- It works by inhibiting bacterial cell wall synthesis and has a **longer half-life** than vancomycin, allowing for less frequent dosing.
*Linezolid*
- **Linezolid** is an oxazolidinone antibiotic known for its activity against **Gram-positive bacteria**, including **MRSA** and vancomycin-resistant enterococci (VRE).
- It inhibits protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex.
Detection of Antimicrobial Resistance Indian Medical PG Question 4: What is the mechanism of resistance in MRSA?
- A. PBP2a alteration (Correct Answer)
- B. Efflux pump activation
- C. Porins modification
- D. Beta-lactamase production
Detection of Antimicrobial Resistance Explanation: ***PBP2a alteration***
- Methicillin-resistant Staphylococcus aureus (MRSA) acquires the **mecA gene**, which encodes for a modified penicillin-binding protein, **PBP2a**.
- **PBP2a** has a low affinity for **beta-lactam antibiotics**, allowing the bacteria to synthesize its cell wall even in the presence of these drugs.
*Efflux pump activation*
- Efflux pumps are mechanisms used by bacteria to actively pump out various antibiotics from their cells, leading to resistance.
- While efflux pumps contribute to resistance against other antibiotics, they are **not the primary mechanism** of methicillin resistance in MRSA.
*Porins modification*
- Porins are channels in the outer membrane of Gram-negative bacteria that allow the passage of hydrophilic molecules, including some antibiotics.
- Modification of porins is a common resistance mechanism in **Gram-negative bacteria** but is not relevant to MRSA, which is Gram-positive.
*Beta-lactamase production*
- Beta-lactamases are enzymes that **hydrolyze the beta-lactam ring** of antibiotics like penicillin, rendering them inactive.
- While many Staphylococcus aureus strains produce beta-lactamase (penicillinase) causing resistance to penicillins, MRSA's resistance to methicillin and other broader-spectrum beta-lactams is primarily due to **PBP2a alteration**, not just beta-lactamase production.
Detection of Antimicrobial Resistance Indian Medical PG Question 5: All of the following are true about methicillin resistance in MRSA, except:
- A. Resistance is produced as a result of altered PBPs
- B. Resistance may be missed at incubation temperature of 37°C during susceptibility testing
- C. Resistance is primarily mediated/transmitted by plasmids (Correct Answer)
- D. Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics
Detection of Antimicrobial Resistance Explanation: ***Resistance is primarily mediated/transmitted by plasmids***
- Methicillin resistance in MRSA is primarily mediated by the acquisition of the **mecA gene**, which encodes for an altered **penicillin-binding protein (PBP2a)**.
- The mecA gene is located on a **staphylococcal chromosomal cassette mec (SCCmec)**, a mobile genetic element integrated into the bacterial chromosome, and **not transmitted via plasmids**.
- This is the **false statement** and hence the correct answer to this "except" question.
*Resistance is produced as a result of altered PBPs*
- This statement is **true** as MRSA acquires the **mecA gene**, which encodes for an altered penicillin-binding protein, **PBP2a**.
- **PBP2a** has a low affinity for beta-lactam antibiotics, allowing the bacterium to synthesize its cell wall even in the presence of these drugs.
*Resistance may be missed at incubation temperature of 37°C during susceptibility testing*
- This statement is **true**; **MRSA expression** can be heterogeneous and temperature-dependent.
- Optimal detection of methicillin resistance often requires incubation at **lower temperatures (e.g., 30-35°C)** and/or the addition of salt (2-4% NaCl), as 37°C can sometimes mask the heterogeneous expression of resistance.
*Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics*
- This statement is **true**; the presence of **PBP2a** results in reduced binding of beta-lactam antibiotics to their target.
- This leads to **increased MICs** for methicillin and other beta-lactam antibiotics, defining the resistance phenotype.
Detection of Antimicrobial Resistance Indian Medical PG Question 6: Which of the following is NOT a criterion for defining extensively drug-resistant tuberculosis (XDR-TB)?
- A. Isoniazid + Rifampicin + Fluoroquinolone
- B. Isoniazid + Rifampicin + Ethambutol + Fluoroquinolone
- C. Fluoroquinolone (Correct Answer)
- D. Isoniazid + Rifampicin + Kanamycin
Detection of Antimicrobial Resistance Explanation: ***Fluoroquinolone***
- Resistance to **fluoroquinolone alone** is NOT a criterion for XDR-TB because XDR-TB requires a **baseline of MDR-TB** (resistance to both rifampicin and isoniazid) plus additional resistances.
- XDR-TB definition (WHO 2021): **MDR-TB** + resistance to **any fluoroquinolone** + resistance to **at least one Group A drug** (bedaquiline or linezolid).
- Fluoroquinolone resistance in isolation does not meet any of these combined criteria.
*Isoniazid + Rifampicin + Fluoroquinolone*
- This represents **MDR-TB** (rifampicin + isoniazid resistance) plus **fluoroquinolone resistance**.
- This is a partial criterion approaching XDR-TB but still requires additional resistance to at least one Group A drug (bedaquiline or linezolid) for complete XDR-TB classification.
- However, this combination includes the essential MDR-TB base and fluoroquinolone component.
*Isoniazid + Rifampicin + Ethambutol + Fluoroquinolone*
- This includes **MDR-TB** (rifampicin + isoniazid), **fluoroquinolone resistance**, and ethambutol (first-line drug).
- While ethambutol resistance alone doesn't define XDR-TB, this combination includes the critical MDR-TB and fluoroquinolone components required for XDR-TB classification.
- Similar to above, would need Group A drug resistance for complete XDR-TB.
*Isoniazid + Rifampicin + Kanamycin*
- This represents **MDR-TB** plus resistance to **kanamycin** (a second-line injectable).
- Under previous WHO definitions (pre-2021), injectable resistance was part of XDR-TB criteria.
- This combination includes the MDR-TB base essential for any XDR-TB classification, though it lacks fluoroquinolone resistance.
Detection of Antimicrobial Resistance Indian Medical PG Question 7: Burkholderia cepacia is intrinsically resistant to:
- A. Ciprofloxacin
- B. Ceftriaxone
- C. Polymyxin B (Correct Answer)
- D. Ampicillin
Detection of Antimicrobial Resistance Explanation: ***Polymyxin B***
- *Burkholderia cepacia* demonstrates **classic intrinsic resistance** to **polymyxins (Polymyxin B and Colistin/Polymyxin E)**
- **Mechanism**: Modifications in the **lipopolysaccharide (LPS) structure** of the outer membrane, particularly alterations in lipid A, reduce polymyxin binding
- This resistance is **chromosomally encoded** and present in all strains, making polymyxins completely ineffective against *B. cepacia* infections
- This is the **most characteristic example** of intrinsic resistance in this organism
*Ciprofloxacin*
- *B. cepacia* is **NOT intrinsically resistant** to ciprofloxacin
- Ciprofloxacin may retain activity and is sometimes used in susceptible strains
- Resistance can develop through **acquired mechanisms** (efflux pumps, DNA gyrase mutations), but this is not inherent to all strains
- Susceptibility testing is essential before use
*Ceftriaxone*
- *B. cepacia* shows resistance to third-generation cephalosporins like ceftriaxone through **multiple resistance mechanisms** including chromosomal AmpC beta-lactamases and efflux pumps
- While this resistance is widespread, it's **less characteristic** as a defining feature compared to polymyxin resistance
- The beta-lactam resistance pattern in *B. cepacia* is complex and variable
*Ampicillin*
- *B. cepacia* is resistant to aminopenicillins like ampicillin through **chromosomal beta-lactamase production** and poor outer membrane permeability
- While present in most strains, this resistance mechanism is **common to many Gram-negative bacteria** and not a distinguishing feature
- Ampicillin is not considered for *B. cepacia* treatment
Detection of Antimicrobial Resistance Indian Medical PG Question 8: Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
- A. Carbapenems (Correct Answer)
- B. Oxyimino-cephalosporins
- C. Penicillins
- D. Cephalosporins
Detection of Antimicrobial Resistance Explanation: ***Carbapenems***
- **Extended-spectrum beta-lactamases (ESBLs)** typically do not hydrolyze **carbapenems**, making these antibiotics generally effective against most ESBL-producing bacteria.
- The retention of activity against carbapenems is a key distinction between ESBLs and other beta-lactamases like **carbapenemases**.
*Oxyimino-cephalosporins*
- ESBLs are specifically named for their ability to hydrolyze and inactivate **oxyimino-cephalosporins**, such as **cefotaxime**, **ceftriaxone**, and **ceftazidime**.
- This hydrolysis makes these vital third-generation cephalosporins ineffective for treating infections caused by ESBL-producing organisms.
*Penicillins*
- ESBLs can effectively hydrolyze and render many **penicillins** inactive, especially those lacking beta-lactamase inhibitors.
- This broadens the resistance spectrum beyond just cephalosporins to include common penicillins.
*Cephalosporins*
- ESBLs primarily confer resistance to a wide range of **cephalosporins**, particularly the **first-, second-, and third-generation agents**.
- This resistance is a major clinical challenge, necessitating the use of alternative antibiotic classes.
Detection of Antimicrobial Resistance Indian Medical PG Question 9: Which antimicrobial resistance mechanism is most commonly associated with extended-spectrum cephalosporin resistance in Neisseria gonorrhoeae?
- A. PenA mosaic alleles (Correct Answer)
- B. mtrR promoter mutation
- C. 23S rRNA methylation
- D. TetM plasmid
Detection of Antimicrobial Resistance Explanation: ***PenA mosaic alleles***
- **PenA mosaic alleles** are altered forms of the gene encoding **penicillin-binding protein 2 (PBP2)**, which is the primary target of cephalosporin antibiotics in *Neisseria gonorrhoeae*. These mosaic alleles result from recombination events with homologous genes from commensal *Neisseria* species.
- The altered PBP2 has **reduced affinity for cephalosporins**, making the bacteria resistant to this class of antibiotics, including extended-spectrum cephalosporins.
*mtrR promoter mutation*
- A **mutation in the *mtrR* promoter** typically leads to overexpression of the **MtrCDE efflux pump**, which pumps out various antimicrobial agents, including some macrolides, disinfectants, and bile salts.
- While it contributes to multidrug resistance, its primary role is not in mediating high-level resistance to extended-spectrum cephalosporins in *N. gonorrhoeae*.
*23S rRNA methylation*
- **23S rRNA methylation** is a common mechanism of resistance to **macrolide antibiotics** (e.g., azithromycin), which bind to the 50S ribosomal subunit.
- This mechanism interferes with macrolide binding to the ribosome, but it does not directly affect the activity of cephalosporins, which target bacterial cell wall synthesis.
*TetM plasmid*
- The **TetM plasmid** confers resistance to **tetracycline antibiotics** by protecting the bacterial ribosome from their action. TetM is a ribosomal protection protein.
- This plasmid is a well-known mechanism of tetracycline resistance in many bacteria, including *N. gonorrhoeae*, but it is not involved in resistance to cephalosporins.
Detection of Antimicrobial Resistance Indian Medical PG Question 10: Organism showing marked resistance to multidrug therapy -
- A. Haemophilus ducreyi
- B. Calymmatobacterium granulomatosis
- C. Treponema pallidum
- D. Gonococci (Correct Answer)
Detection of Antimicrobial Resistance Explanation: ***Gonococci***
- **Gonococci (Neisseria gonorrhoeae)** increasingly show **resistance to multiple antibiotics**, including penicillin, tetracycline, macrolides, and some cephalosporins, making treatment challenging.
- The Centers for Disease Control and Prevention (CDC) recommends **dual therapy with ceftriaxone and azithromycin** to overcome rising resistance.
*Haemophilus ducreyi*
- **Haemophilus ducreyi**, the causative agent of **chancroid**, is typically susceptible to macrolides and cephalosporins, with **less reported multidrug resistance** compared to gonococci.
- Single-dose therapy with **azithromycin or ceftriaxone** is usually effective.
*Calymmatobacterium granulomatosis*
- Now known as **Klebsiella granulomatis**, this organism causes **donovanosis (granuloma inguinale)**, and it is generally sensitive to **doxycycline**, **azithromycin**, or ciprofloxacin.
- While prolonged treatment may be needed, **widespread multidrug resistance** is not characteristic.
*Treponema pallidum*
- **Treponema pallidum**, which causes **syphilis**, remains exquisitely susceptible to **penicillin**, which is the gold standard treatment.
- There is **no significant reported multidrug resistance** to penicillin, although macrolide resistance has emerged in some regions.
More Detection of Antimicrobial Resistance Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
